BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Large Growth in Short Interest

BioNexus Gene Lab Corp. (NASDAQ:BGLCGet Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 197,100 shares, a growth of 164.6% from the November 30th total of 74,500 shares. Based on an average daily volume of 602,900 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.7% of the company’s shares are short sold.

BioNexus Gene Lab Stock Performance

BioNexus Gene Lab stock opened at $0.24 on Friday. BioNexus Gene Lab has a 52-week low of $0.21 and a 52-week high of $3.39. The firm has a 50 day moving average price of $0.31 and a two-hundred day moving average price of $0.40.

About BioNexus Gene Lab

(Get Free Report)

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.

Featured Stories

Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.